APPLICATION
ANDA062798
TYPE
ANDA
ORIGINAL APPROVAL
1995-12-11
LATEST ACTION
2020-02-07
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
OXACILLIN SODIUMDiscontinued
OXACILLIN SODIUM EQ 250MG BASE/VIAL · INJECTABLE · INJECTION
OXACILLIN SODIUMDiscontinued
OXACILLIN SODIUM EQ 2GM BASE/VIAL · INJECTABLE · INJECTION
OXACILLIN SODIUMDiscontinued
OXACILLIN SODIUM EQ 500MG BASE/VIAL · INJECTABLE · INJECTION
OXACILLIN SODIUMDiscontinued
OXACILLIN SODIUM EQ 125MG BASE/VIAL · INJECTABLE · INJECTION
OXACILLIN SODIUMDiscontinued
OXACILLIN SODIUM EQ 1GM BASE/VIAL · INJECTABLE · INJECTION
Approval history
2020-02-07Labeling · Supplement 1 · standardAP
1995-12-11OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.